Literature DB >> 9539722

A novel glutamine-RNA interaction identified by screening libraries in mammalian cells.

R Tan1, A D Frankel.   

Abstract

The arginine-rich motif provides a versatile framework for RNA recognition in which few amino acids other than arginine are needed to mediate specific binding. Using a mammalian screening system based on transcriptional activation by HIV Tat, we identified novel arginine-rich peptides from combinatorial libraries that bind tightly to the Rev response element of HIV. Remarkably, a single glutamine, but not asparagine, within a stretch of polyarginine can mediate high-affinity binding. These results, together with the structure of a Rev peptide-Rev response element complex, suggest that the carboxamide groups of glutamine or asparagine are well-suited to hydrogen bond to G-A base pairs and begin to establish an RNA recognition code for the arginine-rich motif. The screening approach may provide a relatively general method for screening expression libraries in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9539722      PMCID: PMC22474          DOI: 10.1073/pnas.95.8.4247

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  HIV-1 Tat overcomes inefficient transcriptional elongation in vitro.

Authors:  M F Laspia; P Wendel; M B Mathews
Journal:  J Mol Biol       Date:  1993-08-05       Impact factor: 5.469

2.  RNA recognition by an isolated alpha helix.

Authors:  R Tan; L Chen; J A Buettner; D Hudson; A D Frankel
Journal:  Cell       Date:  1993-06-04       Impact factor: 41.582

Review 3.  Developments in expression cloning.

Authors:  B Seed
Journal:  Curr Opin Biotechnol       Date:  1995-10       Impact factor: 9.740

4.  Structural variety of arginine-rich RNA-binding peptides.

Authors:  R Tan; A D Frankel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

5.  Selection of RNA-binding peptides in vivo.

Authors:  K Harada; S S Martin; A D Frankel
Journal:  Nature       Date:  1996-03-14       Impact factor: 49.962

6.  RNA aptamers selected to bind human immunodeficiency virus type 1 Rev in vitro are Rev responsive in vivo.

Authors:  T L Symensma; L Giver; M Zapp; G B Takle; A D Ellington
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

7.  Analysis of RNA-binding proteins by in vitro genetic selection: identification of an amino acid residue important for locking U1A onto its RNA target.

Authors:  I A Laird-Offringa; J G Belasco
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

8.  Crystal structure at 1.92 A resolution of the RNA-binding domain of the U1A spliceosomal protein complexed with an RNA hairpin.

Authors:  C Oubridge; N Ito; P R Evans; C H Teo; K Nagai
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

9.  Solution structure of a bovine immunodeficiency virus Tat-TAR peptide-RNA complex.

Authors:  J D Puglisi; L Chen; S Blanchard; A D Frankel
Journal:  Science       Date:  1995-11-17       Impact factor: 47.728

10.  Costabilization of peptide and RNA structure in an HIV Rev peptide-RRE complex.

Authors:  R Tan; A D Frankel
Journal:  Biochemistry       Date:  1994-12-06       Impact factor: 3.162

View more
  25 in total

1.  Structure-based design of an RNA-binding zinc finger.

Authors:  D J McColl; C D Honchell; A D Frankel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Novel fluorescence-based screen to identify small synthetic internal ribosome entry site elements.

Authors:  A Venkatesan; A Dasgupta
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

3.  Positive and negative mutant selection in the human histone hairpin-binding protein using the yeast three-hybrid system.

Authors:  F Martin; F Michel; D Zenklusen; B Müller; D Schümperli
Journal:  Nucleic Acids Res       Date:  2000-04-01       Impact factor: 16.971

4.  Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.

Authors:  Baode Xie; Valerie Calabro; Mark A Wainberg; Alan D Frankel
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

5.  Selection of RRE RNA binding peptides using a kanamycin antitermination assay.

Authors:  Hadas Peled-Zehavi; Satoru Horiya; Chandreyee Das; Kazuo Harada; Alan D Frankel
Journal:  RNA       Date:  2003-02       Impact factor: 4.942

6.  Evolvability of the mode of peptide binding by an RNA.

Authors:  Tetsuya Iwazaki; Xianglan Li; Kazuo Harada
Journal:  RNA       Date:  2005-07-25       Impact factor: 4.942

7.  Recognition of RNA branch point sequences by the KH domain of splicing factor 1 (mammalian branch point binding protein) in a splicing factor complex.

Authors:  H Peled-Zehavi; J A Berglund; M Rosbash; A D Frankel
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

8.  An alpha-helical peptidomimetic inhibitor of the HIV-1 Rev-RRE interaction.

Authors:  Nicholas L Mills; Matthew D Daugherty; Alan D Frankel; R Kiplin Guy
Journal:  J Am Chem Soc       Date:  2006-03-22       Impact factor: 15.419

9.  The arginine-rich RNA-binding motif of HIV-1 Rev is intrinsically disordered and folds upon RRE binding.

Authors:  Fabio Casu; Brendan M Duggan; Mirko Hennig
Journal:  Biophys J       Date:  2013-08-20       Impact factor: 4.033

10.  Targeting tat inhibitors in the assembly of human immunodeficiency virus type 1 transcription complexes.

Authors:  Iván D'Orso; Jocelyn R Grunwell; Robert L Nakamura; Chandreyee Das; Alan D Frankel
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.